March 12, 2025
Next-generation sequencing (NGS) has transformed genomics, enabling researchers to sequence entire genomes in days. NGS accelerates data collection by simultaneously sequencing millions of DNA fragments, making it faster and more detailed.
In the biomedical field, NGS isn’t just a new tool—it’s essential. Whether studying cancer, exploring gene therapies, or working on personalized medicine, NGS plays a key role in advancing research.
This article explains the basics of NGS, how it works, the different methods, and its applications in modern science.
NGS refers to several technologies that allow high-throughput sequencing of DNA and RNA. By sequencing millions or even billions of DNA fragments in one run, NGS dramatically increases the scale and speed of sequencing, making it more affordable and efficient than traditional methods.
NGS provides valuable insights into genetic variations, gene expression, and epigenetic changes, opening up new possibilities for research.
Sanger sequencing, introduced in 1977, is known for its accuracy and longer read lengths but is slow and costly. For example, sequencing the first human genome cost almost $3 billion and took 13 years.
In contrast, NGS produces millions of reads in just a few hours or days. By significantly reducing time and cost, NGS is ideal for large-scale studies, including whole-genome sequencing and transcriptome analysis.
The key features of NGS include,
NGS has changed how we analyze genetic material, speeding up research in personalized medicine, cancer genomics, and infectious diseases.
NGS helps identify genetic variants and gene expression changes linked to diseases, offering valuable insights for clinical applications. NGS workflows involve several key steps: nucleic acid extraction, library preparation, sequencing, and data analysis.
This workflow is essential for genomic research and personalized medicine, offering insights into complex diseases and enabling targeted therapies.
Now that we have discussed the NGS workflow steps let's explore various applications of NGS in the modern biomedical field.
Next-generation sequencing (NGS) has emerged as a transformative technology in genomics, enabling many applications across various fields. This includes genomics research, cancer studies, microbiome analysis, disease diagnosis, and precision medicine. This section outlines the key applications of NGS, emphasizing its modern and scientifically validated uses.
NGS has transformed genomics by enabling faster, more accurate genetic analysis and advancing fields such as personalized medicine, cancer research, and infectious disease studies. Targeted sequencing focuses on specific genes or genomic regions of interest, enabling detailed studies of genetic variants associated with diseases or traits.
For example, Illumina's high-throughput single-cell CRISPR tool makes gene editing and analysis more precise, focusing on individual cells. Now, researchers can tweak and examine specific genes in over 100,000 cells at once, which opens up a whole new level of understanding of how genes work and how they’re tied to diseases. Combining CRISPR with high-throughput sequencing means scientists can zoom in on genetic changes like never before—helping uncover rare mutations and their impact. This breakthrough also plays a key role in pushing personalized medicine forward, making it easier to target treatments based on genetic profiles
NGS has transformed cancer research, pinpointing mutations that fuel tumor growth. Whether through traditional sequencing or innovative liquid biopsies, it enables more precise treatment strategies. As a result, personalized medicine has emerged, offering therapies customized to each patient's unique genetic makeup.
Sharon Osbourne, a popular media personality, has undergone a preventive double mastectomy that was significantly influenced by genetic testing, which revealed a BRCA1 gene mutation. This gene testing allowed her to understand her heightened risk for breast cancer and take proactive steps long before any signs of cancer appeared.
NGS powers microbiome and pathogen research by profiling microbial communities in environments like the human gut, soil, and crops. Sequencing bacteria and viruses reveals microbial diversity in host-microbe interactions and tracks pathogen outbreaks. This high-throughput method aids in managing microbial diseases and boosting crop resilience.
NGS revolutionizes disease diagnosis by quickly identifying genetic mutations linked to conditions like hereditary disorders and cancers. It streamlines testing by analyzing multiple genes at once. In precision medicine, NGS identifies biomarkers to personalize treatments, improving diagnosis accuracy and patient outcomes.
Recently, Freenome announced the results of its PREEMPT CRC study, which validates its blood-based test for early detection of colorectal cancer (CRC) using Next-Generation Sequencing (NGS) and a multiomics platform. The test achieved 79.2% sensitivity for CRC and 91.5% specificity for detecting non-advanced neoplasia. It also demonstrated 12.5% sensitivity for advanced adenomas.
The test achieved 79.2% sensitivity for CRC and 91.5% specificity for non-advanced neoplasia, with 12.5% sensitivity for advanced adenomas. This breakthrough highlights NGS’s potential to detect CRC and pre-cancerous conditions with high accuracy. The blood-based approach offers a non-invasive, accessible, and cost-effective method, making regular cancer screening easier and enabling earlier detection.
NGS is increasingly used in prenatal testing to detect chromosomal abnormalities and genetic disorders in fetuses through non-invasive methods such as cell-free fetal DNA sequencing.
Panorama™ NIPT by Natera exemplifies how NGS is transforming prenatal testing. Using cell-free DNA from the mother’s blood, it accurately detects fetal RhD status, demonstrating 100% sensitivity and 99.3% specificity. This non-invasive test identifies genetic variations in the RHD gene, preventing RhD alloimmunization and reducing the need for invasive procedures. NGS enables early, accurate detection of chromosomal abnormalities and genetic disorders, offering personalized, cost-effective care and improving diagnostic accuracy in prenatal screening.
Also, a study developed by Natera demonstrates the use of cfDNA biomarkers and AI to predict preeclampsia early. By combining cfDNA markers with patient data, the AI model showed 58% sensitivity for preterm preeclampsia, improving early detection. Although cfDNA contributed less to predicting term preeclampsia, it significantly enhanced prediction for early-onset cases. This approach offers a non-invasive, cost-effective method for personalized prenatal care, improving outcomes and clinical decision-making.
Hence, NGS is a vital tool in biomedical research and clinical practice, revolutionizing our understanding of genetics and disease mechanisms. Its speed and accuracy enable advancements in personalized medicine.
As we explore the diverse applications of NGS, it becomes clear how this technology is transforming research and clinical practices. Now, let's dive into the key advantages that make NGS a powerful tool in modern genomics.
Next Generation Sequencing (NGS) has transformed both genomic research and clinical diagnostics, offering several advantages over traditional sequencing methods.
NGS can sequence millions to billions of DNA fragments in one run, dramatically reducing sequencing time and costs compared to traditional methods like Sanger sequencing. This makes it ideal for clinical diagnostics where rapid results are crucial.
NGS quickly generates large volumes of high-resolution data, crucial for diagnosing infectious diseases or monitoring cancer progression. It detects a wide range of genetic variations, including SNPs, deletions, and structural changes, providing comprehensive insights.
NGS excels at detecting rare mutations and low-frequency variants (as low as 1%), essential for understanding complex diseases like cancer. Its deep sequencing and low error rates ensure high accuracy in identifying clinically relevant mutations.
NGS enables efficient, broad genomic analysis, useful in fields like cancer genomics to identify all genetic alterations in tumors, which informs targeted therapies.
NGS is central to precision medicine, allowing for personalized treatment plans based on genetic profiles, improving patient outcomes in cancer, microbiome studies, and other diseases.
While next-generation sequencing (NGS) has revolutionized genomic research and clinical diagnostics, it is essential to acknowledge its inherent challenges and limitations.
While NGS offers remarkable benefits, several challenges remain:
To fully utilize NGS's potential, AI plays a crucial role in streamlining data analysis and improving accuracy.
As NGS produces vast amounts of data, artificial intelligence (AI) plays a crucial role in analyzing this information, extracting valuable insights, and enhancing the accuracy of results.
AI improves NGS data analysis by automating essential tasks, boosting both efficiency and precision. Machine learning algorithms refine their performance over time, allowing for more accurate disease detection and treatment.
One major application is sequence alignment to a reference genome, a critical step in identifying genetic variations and mutations. AI algorithms streamline this process, ensuring accurate matches while correcting errors and variations in the data.
NGS generates massive datasets that require swift processing. AI, especially deep learning models, helps accelerate data interpretation. These models can quickly analyze genetic variations, reducing the time and resources needed for detailed analysis.
AI is invaluable in identifying genetic mutations related to rare diseases. It helps predict disease-causing genes and types of mutations, significantly speeding up diagnoses and reducing costs by improving the efficiency of bioinformatics tools used in alignment, variant calling, and annotation.
AI enhances pathogen detection by rapidly processing NGS data, aiding in timely infectious disease diagnoses. AI algorithms, combined with extensive databases like NCBI and EMBL-EBI and knowledge bases, can significantly improve the accuracy of pathogen identification and classification.
For example, Kraken2 is a highly efficient pathogen classification tool that uses AI technology and a comprehensive reference database to enable rapid analysis of NGS data.
AI-powered pipelines improve the precision of variant calling, filtering out irrelevant data and prioritizing potentially harmful variants. This helps clinicians identify genetic causes and personalize treatments more effectively.
However, while AI has advanced in identifying potential variants, interpreting some complex or novel genetic mutations requires expert review. This highlights the need for human oversight in clinical applications, especially for rare variants whose significance may not be fully understood yet.
AI's integration into NGS transforms data analysis, making it faster, more accurate, and cost-efficient.
NGS has transformed genomics by enabling faster, more accurate sequencing. Its applications span genomic research, cancer studies, microbiome analysis, and precision medicine, making it an indispensable tool for researchers and clinicians alike.
As genomics research advances, the need for affordable, high-quality RNA sequencing has never been more pressing. Biostate AI is leading the way, offering cost-effective and scalable total RNA sequencing. Whether you're exploring longitudinal changes, multi-organ effects, or individual genetic variations, our RNASeq solutions allow researchers to focus on what truly matters: advancing science.
Our simplified process takes you from sample to insight, saving time and money while delivering valuable, actionable data. With flexible options for a range of sample types, from blood and tissue to cultured cells, Biostate AI ensures that your research goals are met with precision and efficiency.
Ready to elevate your research? Take advantage of our affordable RNASeq services, with a special offer for academic institutions. Contact us today for a free consultation, and let Biostate AI be your trusted partner in advancing scientific discovery.
